Robert Iannone
Chief Tech/Sci/R&D Officer at JAZZ PHARMACEUTICALS PLC
Net worth: 6 M $ as of 2024-04-29
Robert Iannone active positions
| Companies | Position | Start | End |
|---|---|---|---|
| JAZZ PHARMACEUTICALS PLC | Chief Tech/Sci/R&D Officer | 2019-05-28 | - |
| ITEOS THERAPEUTICS, INC. | Director/Board Member | 2021-05-02 | - |
| Independent Dir/Board Member | 2021-05-02 | - | |
| AUTOLUS THERAPEUTICS PLC | Director/Board Member | 2023-06-19 | - |
Jazz Pharmaceuticals, Inc.
 Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Chief Tech/Sci/R&D Officer | 2019-04-30 | - |
Career history of Robert Iannone
Former positions of Robert Iannone
| Companies | Position | Start | End |
|---|---|---|---|
| JOUNCE THERAPEUTICS, INC. | Director/Board Member | 2020-01-20 | 2023-05-02 |
| Independent Dir/Board Member | 2020-01-20 | 2023-05-02 | |
| IMMUNOMEDICS, INC. | Chief Tech/Sci/R&D Officer | 2018-04-08 | 2019-05-27 |
| ASTRAZENECA PLC | Corporate Officer/Principal | 2014-06-30 | 2018-03-31 |
| MERCK & CO., INC. | Director/Board Member | 2008-02-29 | 2014-06-30 |
| Corporate Officer/Principal | 2008-02-29 | 2014-06-30 | |
| University of Pennsylvania Medical Center | Corporate Officer/Principal | 2000-12-31 | 2011-12-31 |
Training of Robert Iannone
| University of Pennsylvania Medical Center | Graduate Degree |
| The Catholic University of America | Undergraduate Degree |
| Yale University | Doctorate Degree |
Statistics
International
| United States | 9 |
| United Kingdom | 3 |
| Ireland | 2 |
Operational
| Director/Board Member | 4 |
| Corporate Officer/Principal | 3 |
| Chief Tech/Sci/R&D Officer | 3 |
Sectoral
| Health Technology | 8 |
| Consumer Services | 4 |
| Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 5 |
|---|---|
| ASTRAZENECA PLC | Health Technology |
| JAZZ PHARMACEUTICALS PLC | Health Technology |
| MERCK & CO., INC. | Health Technology |
| ITEOS THERAPEUTICS, INC. | Health Technology |
| AUTOLUS THERAPEUTICS PLC | Health Technology |
| Private companies | 3 |
|---|---|
Immunomedics, Inc.
 Immunomedics, Inc. BiotechnologyHealth Technology Immunomedics, Inc. researching, developing, manufacturing, and marketing biopharmaceutical products. It focuses on monoclonal antibody-based products for the targeted treatment of cancer. The company was founded by David M. Goldenberg in July 1982 and is headquartered in Morris Plains, NJ. | Health Technology |
Jounce Therapeutics, Inc.
 Jounce Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Jounce Therapeutics, Inc. is a clinical stage immunotherapy company, which engages in developing treatments for cancer. It also provides novel cancer immunotherapies to attack tumors. The company was founded by Louis M. Weiner, Drew M. Pardoll, Thomas F. Gajewski, James P. Allison, Robert Schreiber, and Padmanee Sharma in 2013 and is headquartered in Cambridge, MA. | Commercial Services |
Jazz Pharmaceuticals, Inc.
Jazz Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Jazz Pharmaceuticals, Inc. develops and markets pharmaceutical products. Its medical products include xyrem, erwinaze, vyxeos, and kidrolas. The company was founded by Bruce C. Cozadd in 2003 and is headquartered in Palo Alto, CA. | Health Technology |
- Stock Market
- Insiders
- Robert Iannone
- Experience
